Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-21

FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)

View source ↗

Summary

FDA approved a supplemental application for Claritin (loratadine) held by Bayer HealthCare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin (loratadine)

Snippet

SUPPL AP for CLARITIN (LORATADINE)